American Journal of Kidney Diseases
Volume 55, Issue 4 , Pages 682-689 , April 2010

Long-term Effects of Arteriovenous Fistula Closure on Echocardiographic Functional and Structural Findings in Hemodialysis Patients: A Prospective Study

  • Ezio Movilli, MD

      Affiliations

    • Division of Nephrology, Spedali Civili, and Section of Nephrology, University of Brescia, Brescia, Italy
    • Corresponding Author InformationAddress correspondence to Ezio Movilli, MD, Spedali Civili and University of Brescia, Piazzale Spedali Civili 1, Brescia, 25125 Italy
    • ,
  • Battista Fabio Viola, MD

      Affiliations

    • Division of Nephrology, Spedali Civili, and Section of Nephrology, University of Brescia, Brescia, Italy
    • ,
  • Giuliano Brunori, MD

      Affiliations

    • Department of Nephrology, Santa Chiara Hospital, Trento, Italy
    • ,
  • Paola Gaggia, MD

      Affiliations

    • Division of Nephrology, Spedali Civili, and Section of Nephrology, University of Brescia, Brescia, Italy
    • ,
  • Corrado Camerini, MD

      Affiliations

    • Division of Nephrology, Spedali Civili, and Section of Nephrology, University of Brescia, Brescia, Italy
    • ,
  • Roberto Zubani, MD

      Affiliations

    • Division of Nephrology, Spedali Civili, and Section of Nephrology, University of Brescia, Brescia, Italy
    • ,
  • Nicola Berlinghieri, MD

      Affiliations

    • Unit of Cardiology, Spedali Civili, and Cardiology, University of Brescia, Brescia, Italy
    • ,
  • Giovanni Cancarini, MD

      Affiliations

    • Division of Nephrology, Spedali Civili, and Section of Nephrology, University of Brescia, Brescia, Italy

Received 6 April 2009 ,Accepted 4 November 2009.

References 

  1. MacRae JM, Levin A, Belenkie I. The cardiovascular effects of arteriovenous fistulas in chronic kidney disease: a cause for concern?. Semin Dial. 2006;19:349–352
  2. Canaud B, Krieter DH. High-flux renal replacement therapies. In:  Nissenson AR,  Fine RN editor. Clinical Dialysis. 4th ed.. New York: McGraw-Hill Companies; 2005;p. 949–962
  3. Unger P, Wissing KM. Arteriovenous fistula after transplantation: utility, futility or threat?. Nephrol Dial Transplant. 2006;21:254–257
  4. Bossola M, Tazza L, Vulpio C, Luciani G. Is regression of left ventricular hypertrophy in hemodialysis patients possible?. Semin Dial. 2008;21:422–430
  5. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1993;4:1205–1213
  6. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358–367
  7. Ganau A, Devereux EB, Roman JM, et al. Patterns of left ventricular hypertrophy and geometry remodelling in essential hypertension. J Am Coll Cardiol. 1992;19:1550–1558
  8. Levi D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for the left ventricular hypertrophy: the Framingham Study. Am J Cardiol. 1987;59:956–960
  9. Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol. 1994;4:1486–1490
  10. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during long term antihypertensive treatment. J Hypertens. 1995;13:1091–1095
  11. Cannella G, La Canna S, Sandrini M, et al. Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients. Nephrol Dial Transplant. 1991;6:31–37
  12. Meeus F, Kourilsky O, Guerin AP, Gaudry C, Marchais SJ, London GM. Pathophysiology of cardiovascular disease in hemodialysis patients. Kidney Int Suppl. 2000;76:S140–S147
  13. Charra B. Fluid balance, dry weight, and blood pressure in dialysis. Hemodial Int. 2007;11:21–31
  14. Alpert MA. Cardiac performance and morphology in end-stage renal disease. Am J Med Sci. 2003;325:168–178
  15. London GM. Left ventricular hypertrophy: why does it happen?. Nephrol Dial Transplant. 2003;18(suppl 8):2–6
  16. Burrows L, Muller R. Chronic kidney disease and cardiovascular disease: pathophysiologic links. Nephrol Nurs J. 2007;34:55–63
  17. Portolés J, Torralbo A, Martin P, Rodrigo J, Herrero JA, Barrientos A. Cardiovascular effects of recombinant human erythropoietin in pre dialysis patients. Am J Kidney Dis. 1997;29:541–548
  18. Bárány P, Müller HJ. Maintaining control over haemoglobin levels: optimizing the management of anaemia in chronic kidney disease. Nephrol Dial Transplant. 2007;22(suppl 4):10–18
  19. Basile C, Lomonte C, Vernaglione L, Casucci F, Antonelli M, Losurdo N. The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant. 2008;23:282–287
  20. Berkoben MS, Schwab SJ. Vascular access for hemodialysis. In:  Nissensson A,  Fine RN editor. Clinical Dialysis. 4th edition. New York: McGraw-Hill Companies; 2005;p. 27–45
  21. National Kidney Foundation. K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Vascular Access 2006. Am J Kidney Dis. 2006;48(suppl 1):S176–S322

 Originally published online as doi:10.1053/j.ajkd.2009.11.008 on January 20, 2010.

PII: S0272-6386(09)01565-0

doi: 10.1053/j.ajkd.2009.11.008

American Journal of Kidney Diseases
Volume 55, Issue 4 , Pages 682-689 , April 2010

Article Tools

* Image Usage & Resolution